Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Zindaclin launched in the U.K. as once-daily acne treatment

March 27, 2002

Cellegy submits NDS for Rectogesic approval in Canada

March 27, 2002

Licensing opportunity from NIH: use of CpG oligodeoxynucleotides to promote angiogenesis

March 26, 2002

Novel antibiotic for acne enters phase I testing

March 26, 2002

Daclizumab fails to meet endpoint as maintenance treatment in psoriasis

March 22, 2002

Investigators at Shiseido identify new MMP inhibitors

March 21, 2002

Centocor patents series of anti-IL-12 antibodies

March 21, 2002

First European country approves Elidel for atopic dermatitis

March 19, 2002

Optimal treatment regimen for Vasogen's immune modulation therapy identified

March 18, 2002

Protopic cleared for launch in Europe

March 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...